Polyglycolic Acid Felt Sealing Method for Prevention of Bleeding Related to Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents

Table 1

Baseline characteristics of patients and tumors.

	Sealing group; ()	Nonsealing group; ()	Discontinuation group; ()	Nonantithrombotic therapy group; ()
Mean age (years)	74.8 ± 7.1	75.2 ± 9.2	74.8 ± 6.9	68.9 ± 9.8
Sex (males/females)	76/28	52/18	27/9	504/220
Tumor location (E/S/C)	28/48/28	11/44/15	5/23/8	206/343/175
Mean resection size (mm)	43.4 ± 13.4	45.3 ± 14.5	43.8 ± 16.8	44.5 ± 16.3
Antithrombotics				—
Antiplatelets	86	45	35
Low dose aspirin only	53	28	12
Thienopyridine only	10	4	0
DAPT	10	4	4
Anticoagulants	19	26	1
NOAC	9	2	1

E/S/C: esophagus/stomach/colon; DAPT: dual antiplatelet therapy; NOAC: novel oral anticoagulant.